Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Current ratio

Current ratio at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
0.9×0.0×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
7.1×+1.0×
Avanos Medical logo
Avanos MedicalAVNS
2.5×-0.1×
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
4.7×+2.3×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
2×-0.5×
Theravance Biopharma logo
Theravance BiopharmaTBPH
13.1×+8.4×

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

total current assets/total current liabilities=1.7×

Based on the most recent quarter.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s current ratio?
Collegium Pharmaceutical, Inc. (COLL) reported current ratio of 1.7× in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s current ratio changed year-over-year?
Collegium Pharmaceutical, Inc.'s current ratio increased by 58.2% year-over-year, from 1.1× to 1.7×.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s current ratio?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s current ratio has grown at a 6.2% compound annual growth rate (CAGR), from 1.2× to 1.6×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.